Company Overview

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

  • Name

    Colgate-Palmolive Company

  • CEO

    Mr. Noel R. Wallace

  • Website

    www.colgatepalmolive.com

  • Sector

    Household Products

  • Year Founded

    1806

Profile

  • Market Cap

    $83.35B

  • EV

    $91.05B

  • Shares Out

    817.09M

  • Revenue

    $19.99B

  • Employees

    34,000

Margins

  • Gross

    59.7%

  • EBITDA

    24.17%

  • Operating

    21.2%

  • Pre-Tax

    19.62%

  • Net

    14.21%

  • FCF

    16.8%

Returns (5Yr Avg)

  • ROA

    14.85%

  • ROTA

    -136.01%

  • ROE

    747.2%

  • ROCE

    34.17%

  • ROIC

    24.98%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    $105.74

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    $1,335M

  • Net Debt

    $7,341M

  • Debt/Equity

    18

  • EBIT/Interest

    14.46

Growth (CAGR)

  • Rev 3Yr

    5.38%

  • Rev 5Yr

    5.35%

  • Rev 10Yr

    1.38%

  • Dil EPS 3Yr

    2.37%

  • Dil EPS 5Yr

    5.48%

  • Dil EPS 10Yr

    3.68%

  • Rev Fwd 2Yr

    3.81%

  • EBITDA Fwd 2Yr

    7.57%

  • EPS Fwd 2Yr

    9.67%

  • EPS LT Growth Est

    8.99%

Dividends

  • Yield

  • Payout

    56.21%

  • DPS

    $1.94

  • DPS Growth 3Yr

    3.1%

  • DPS Growth 5Yr

    2.8%

  • DPS Growth 10Yr

    3.46%

  • DPS Growth Fwd 2Yr

    4.84%

NYSE:CL